About This Page
This is a clinician-written, evidence-based summary aligned to the USMLE Step 2 CK Content Outline. It is intended for medical students preparing for USMLE Step 2 CK. Management reflects current ACC/AHA, USPSTF, and APA guidelines. Always cross-reference with UpToDate, institutional protocols, and clinical judgment.
The Bottom Line
- Diagnosis requires >=2 weeks of delusions or hallucinations without a major mood episode
- Mood episodes are present for the majority of total illness duration
- Psychosis only during mood episodes = bipolar disorder or MDD with psychotic features
- Treatment requires antipsychotic plus mood stabilizer for bipolar type or antidepressant for depressive type when indicated
- Paliperidone is FDA-approved but exams usually test the timeline
Overview
Schizoaffective disorder requires a major mood episode concurrent with schizophrenia criterion A symptoms, at least 2 weeks of psychosis without mood symptoms, and mood symptoms present for most of the illness duration. Diagnosis is longitudinal and depends on a careful timeline.
Epidemiology
It is less common than schizophrenia or bipolar disorder and is associated with relapse, suicide risk, functional impairment, and substance use. Diagnostic stability is lower because accurate classification requires longitudinal symptom mapping.
Clinical Features
Symptoms
Hallucinations or delusions during and outside mood episodes
Manic or depressive episodes accompanying psychosis
Disorganized speech/behavior or negative symptoms
Suicidal ideation, command hallucinations, severe mania, catatonia, or grave disability
Signs
Responding to internal stimuli or disorganization
Mood-congruent or incongruent affective symptoms
Delirium, intoxication, withdrawal, or neurological signs suggest another cause
Investigations
First-line
Longitudinal timelineMap psychosis and mood symptoms; find any >=2-week psychosis period without mood symptoms
Safety assessmentSuicide, violence, command hallucinations, mania risk, grave disability
Medical/substance evaluationUrine toxicology, CMP, CBC, TSH, pregnancy test, targeted first-episode psychosis workup
Second-line
Collateral historyFamily/records clarify timing and response
Baseline monitoringMetabolic labs, weight/BMI, BP, AIMS, ECG if QT risk, mood stabilizer labs
Specialist
Psychiatry referralRecommended for diagnostic clarification and medication management
1
Acute management
- Hospitalize for danger, grave disability, severe mania, unsafe psychosis, or inability to care for self
- Treat psychosis with antipsychotic medication; consider IM options for severe agitation
- Address intoxication, withdrawal, delirium, or medical causes
2
Subtype-specific treatment
- Bipolar type: antipsychotic plus lithium or valproate when mania is present
- Depressive type: antipsychotic; add antidepressant cautiously when bipolarity is excluded/managed
- Consider LAI for nonadherence or repeated relapse
3
Maintenance
- Continue antipsychotic maintenance
- Use psychoeducation, sleep regularity, substance treatment, family involvement, and supported employment/education
- Monitor cardiometabolic risk and adverse effects
Complications
- Suicide:
- Relapse from nonadherence, sleep loss, or substance use:
- Functional impairment:
- EPS, metabolic syndrome, hyperprolactinemia, lithium/valproate toxicity:
USMLE Step 2 CK Exam Tips
- 1Timeline is the exam key
- 2Psychosis only during mood episodes = mood disorder with psychotic features
- 3Mood symptoms brief relative to psychosis = schizophrenia
- 4Bipolar type requires mania
- 5Collateral history is often the best next step when stable
practicetest your knowledge on schizoaffective disorderApply what you've learnt with USMLE Step 2 CK-style questions from the iatroX Q-Bank — psychiatry and beyond.
open q-bank